Intelligence trajectories in individuals at ultra-high risk for psychosis: An 8-year longitudinal analysis.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
10 2022
Historique:
received: 10 02 2022
revised: 29 06 2022
accepted: 20 08 2022
pubmed: 3 9 2022
medline: 26 10 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Cognitive impairment is a well-documented predictor of transition to a full-threshold psychotic disorder amongst individuals at ultra-high risk (UHR) for psychosis. However, less is known about whether change in cognitive functioning differs between those who do and do not transition. Studies to date have not examined trajectories in intelligence constructs (e.g., acquired knowledge and fluid intelligence), which have demonstrated marked impairments in individuals with schizophrenia. This study aimed to examine intelligence trajectories using longitudinal data spanning an average of eight years, where some participants completed assessments over three time-points. Participants (N = 139) at UHR for psychosis completed the Wechsler Abbreviated Scale of Intelligence (WASI) at each follow-up. Linear mixed-effects models mapped changes in WASI Full-Scale IQ (FSIQ) and T-scores on Vocabulary, Similarities, Block Design, and Matrix Reasoning subtests. The sample showed stable and improving trajectories for FSIQ and all subtests. There were no significant differences in trajectories between those who did and did not transition to psychosis and between individuals with good and poor functional outcomes. However, although not significant, the trajectories of the acquired knowledge subtests diverged between transitioned and non-transitioned individuals (β = -0.12, 95 % CI [-0.29, 0.05] for Vocabulary and β = -0.14, 95 % CI [-0.33, 0.05] for Similarities). Overall, there was no evidence for long-term deterioration in intelligence trajectories in this UHR sample. Future studies with a larger sample of transitioned participants may be needed to explore potential differences in intelligence trajectories between UHR transition groups and other non-psychosis outcomes.

Identifiants

pubmed: 36055017
pii: S0920-9964(22)00309-7
doi: 10.1016/j.schres.2022.08.006
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-148

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicts of interest.

Auteurs

Nicholas Cheng (N)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Ashleigh Lin (A)

Telethon Kids Institute, The University of Western Australia, Perth, Australia.

Stephen Bowden (S)

Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, Australia.

Caroline Gao (C)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Alison R Yung (AR)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia; Division of Psychology and Mental Health, University of Manchester, Manchester, England, UK; Greater Manchester Mental Health NHS Foundation Trust, Manchester, England, UK; Institute for Mental and Physical Health and Clinical Translation, Deakin University, Australia.

Barnaby Nelson (B)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Andrew Thompson (A)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Hok Pan Yuen (HP)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Warrick J Brewer (WJ)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Daniela Cagliarini (D)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Annie Bruxner (A)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Magenta Simmons (M)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Christina Broussard (C)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Christos Pantelis (C)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Parkville, Australia.

Patrick D McGorry (PD)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Kelly Allott (K)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Stephen J Wood (SJ)

Orygen, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia; School of Psychology, University of Birmingham, Edgbaston, UK. Electronic address: stephen.wood@orygen.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH